BALB/c.CBA/N mice carrying the defective Btk(xid) gene are resistant to pristane-induced plasmacytomagenesis

International Immunology

Volumn 11, Issue 7, 1999, Pages 1059-1064

  Potter, Michael ^a   Judith S, Wax ^b   Hansen, Carl T ^c   Kenny, James J ^d  

^a NATIONAL CANCER INSTITUTE   (United States)

^b Perlmmune Inc   (United States)

^c NATIONAL INSTITUTES OF HEALTH   (United States)

^d NATIONAL INSTITUTE ON AGING   (United States)

Author keywords

B 1 lymphocytes; Bruton's tyrosine kinase; CBA N; Plasmacytoma; Pristane; TI 2 antigens; xid

Indexed keywords

PRISTANE; PROTEIN TYROSINE KINASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; B LYMPHOCYTE; CONTROLLED STUDY; FEMALE; GRANULOMA; HETEROZYGOTE; HOMOZYGOTE; MALE; MOUSE; NONHUMAN; PLASMA CELL; PLASMACYTOMA; PRIORITY JOURNAL;

ALLELES; ANIMALS; CARCINOGENS; CROSSES, GENETIC; FEMALE; GENETIC PREDISPOSITION TO DISEASE; MALE; MICE; MICE, INBRED BALB C; MICE, INBRED CBA; PERITONEAL NEOPLASMS; PLASMACYTOMA; PROTEIN-TYROSINE KINASES; TERPENES; X CHROMOSOME;

EID: 0345517293     PISSN: 09538178     EISSN: None     Source Type: Journal    
DOI: 10.1093/intimm/11.7.1059     Document Type: Article

References (46)

1. Vetrie, D., Vorechovsky, I., Sideras, P., Holland, J., Davies, A., Flinter, F., Hammarstrom, L., Kinnon, C., Levinsky, R,. Bobrow, M., Edvard Smith, C. I. and Bentley, D. R. 1993. The gene involved in X-linked agammaglobulinaemia is a member of the src family of protein-tyrosine kinases. Nature 361:226.
2. Tsukada, S., Saffran, D. C., Rawlings, D. J., Parolini, O., Allen, R. C., Klisak, I., Sparkes, R. S., Kubagawa, H., Mohandas, T., Quan, S., Belmont, J. W., Cooper, M. D., Conley, M. E. and Witte, O. N. 1993. Deficient expression of a B cell cytoplasmic tyrosine kinase in human X-linked agammaglobulinemia. Cell 72:279.
3. Thomas, J. D., Sideras, P., Smith, C. I. E., Vorechovsky, I., Chapman, V. and Paul, W. E. 1993. Colocalization of X-linked agammaglobulinemia and X-linked immunodeficiency genes. Science 261:35.
4. Rawlings, D. J., Saffran, D. C., Tsukada, S., Largaespada, D. A., Grimaldi, J. C., Cohen, L., Mohr, R. N., Bazan, J. F., Howard, M., Copeland, N. G., Jenkins, N. A. and Witte, O. N. 1993. Mutation of unique region of Bruton's tyrosine kinase in immunodeficient XID mice. Science 261:358.
5. Rawlings, D. J. and Witte, O. N. 1995. The Btk subfamily of cytoplasmic tyrosine kinases: structure, regulation and function. Semin, Immunol. 7:237.
6. L permits anti-immunoglobulin (Ig)-induced proliferation in xid B cells. J. Exp. Med 187:1081.
7. Brorson, K., Brunswick, M., Ezhevsky, S., Wei, D. G., Berg, R., Scott, D. and Stein, K. E. 1997. xid affects events leading to B cell cycle entry. J. Immunol. 159:135.
8. Anderson, J. S., Teutsch, M., Dong, Z. and Wortis. H. H. 1996. An essential role for Bruton's [corrected] tyrosine kinase in the regulation of B cell apoptosis [published erratum appears in Proc. Natl Acad. Sci. USA 1996; 93(26): 15522], Proc. Natl Acad. Sci. USA 93:10966.
9. Kenny, J. J., Fischer, R. T., Lustig, A., Dintzis, H., Katsumata, M., Reed, J. C. and Longo, D. L. 1996. bcl-2 alters the antigen-driven selection of B cells in mukappa but not in mu-only Xid transgenic mice. J. Immunol. 157:1054.
10. Woodland, R. T., Schmidt, M. R., Korsmeyer, S. J. and Gravel, K. A. 1996. Regulation of B cell survival in xid mice by the protooncogene bcl-2. J. Immunol. 156:2143.
11. L escape negative selection and are tolerized by clonal anergy and receptor editing. Immunity. 9:35.
12. Rosen, F. S., Cooper, M. D. and Wedgwood, R. J. 1995. The primary immunodeficiencies. N. Engl. J. Med. 333:431.
13. Bondada, S. and Garg, M. 1994. Thymus-independent antigens. In E. C. Snow, ed. Handbook of B and T Lymphocytes, p. 343. Academic Press, New York.
14. Scher, I. 1982. CBA/N immune defective mice; evidence for the failure of a B cell subpopulation to be expressed. Immunol. Rev. 64:117.
15. Stall, A. M., Wells, S. M. and Lam, K. P. 1996. B-1 cells: unique origins and functions. Semin. Immunol. 8:45.
16. + (CD5) B cells that recognize phosphatidyl choline. J. Exp. Med. 168:687.
17. Kroese, F. G. M., Butcher, E. C., Stall, A. M., Lalor, P. A., Adams, S. and Herzenberg, L. A 1988. Many of the IgA producing plasma cells in murine gut are derived from self-replenishing precursors in the peritoneal cavity. Int. Immunol. 1:75.
18. + B cell subset. Semin. Immunol. 8:37.
19. Herzenberg, L. A., Kantor, A. B. and Herzenberg, L. A. 1992. Layered evolution in the immune system. A model for the ontogeny and development of multiple lymphocyte lineages. Ann. NY Acad. Sci. 651:1.
20. Kantor, A. B., Stall, A. M., Adams, S., Watanabe, K. and Herzenberg, L. A. 1995. De novo development and self-replenishment of B cells. Int. Immunol. 7:55.
21. Hayakawa, K., Hardy, R. R., Stall, A. M. and Herzenberg, L. A. 1986. Immunoglobulin-bearing B cells reconstitute and maintain the murine Ly-1 B cell lineage. Eur. J. Immunol. 16:1313.
22. Satterthwaite, A. B., Li, Z. and Witte, O. 1998. Btk function in B cell development and response. Semin. Immunol. 10:309.
23. Merwin, R. M. and Redmon, L. W. 1963. Induction of plasma cell tumors and sarcomas in mice by diffusion chambers placed in the peritoneal cavity. J. Natl. Cancer Inst. 31:990.
24. Potter, M., Wax, J. and Jones, G. M. 1997. Indomethacin is a potent inhibitor of pristane and plastic disc induced plasmacytomagenesis in a hypersusceptible BALB/c congenic strain. Blood 90:260.
25. Potter, M. and Wax, J. S. 1983. Peritoneal plasmacytomagenesis in mice: comparison of different pristane dose regimens. J. Natl. Cancer Inst. 71:391.
26. Potter, M., Morrison, S., Wiener, F. and Miller, F. W. 1994. Induction of plasmacytomas with silicons gel in genetically susceptible strains of mice. J. Natl. Cancer Inst. 86:1058.
27. Anderson, A. O., Wax, J. S. and Potter, M. 1985. Differences in the peritoneal response to pristane in BALB/cAnPt and BALB/cJ mice. Curr. Top. Microbiol. Immunol. 122:242.
28. Potter, M., Mushinski, E. B., Wax, J. S., Hartley, J. and Mock, B. A. 1994. Identification of two genes on chromosome 4 that determine resistance to plasmacytoma induction in mice. Cancer Res. 54:969.
29. Potter, M. and Wiener, F. 1992. Plasmacytomagenesis in mice: model of neoplastic development dependent upon chromosomal translocations. Carcinogenesis 13:1681.
30. Amoroso, S. R., Huang, N., Roberts, A. B., Potter, M. and Letterio, J. J. 1998. Consistent loss of functional type beta transforming growth factor receptor expression in murine plasmacytomas. Proc. Natl Acad. Sci. USA 95:189.
31. Taurog, J. D., Raveche, E. S., Smathers, P. A., Glimcher, L. H., Huston, D. P., Hansen, C. T. and Steinberg, A. D. 1981. Studies of the pathogenesis of autoimmunity in NZB mice. Demonstration of independent B and T cell abnormalities and prevention of autoimmunity by deletion of a B cell subset. J. Exp. Med. 153:221.
32. Potter, M., Wax, J. S., Anderson, A. O. and Nordan, R. P. 1985. Inhibition of plasmacytoma development in BALB/c mice by indomethacin. J. Exp. Med. 161:996.
33. Potter, M. 1984. Genetics of susceptibility to plasmacytoma development in BALB/c mice. Cancer Surv. 3:247.
34. Choi, M. S., Holmann, M., Atkins, C. J. and Klaus, G. G. 1996. Expression of bcl-x during mouse B cell differentiation and following activation by various stimuli. Eur. J. Immunol. 26:676.
35. Klaus, G. G., Holman, M., Johnson-Leger, C., Elgueta-Karstegal, C. and Atkins, C. 1997. A re-evaluation of the effects of X-linked immunodeficiency (xid) mutation on B cell differentiation and function in the mouse. Eur. J. Immunol. 27:2749.
36. Gershon, R. K. and Kondo, K. 1976. Deficient production of a thymus-dependent high affinity antibody subset in mice (CBA/N) with an X-linked B lymphocyte defect. J. Immunol. 117:701.
37. Sprent, J., Bruce, J., Ron, Y. and Webb, S. R. 1985. Physiology of B cells in mice with X-linked immunodeficiency. I. Size, migratory properties, and turnover of the B cell pool. J. Immunol. 134:1442.
38. Oka, Y., Rolink, A. G., Andersson, J., Kamanaka, M., Uchida, J., Yasui, T., Kishimoto, T., Kikutani, H. and Melchers, F. 1996. Profound reduction of mature B cell numbers, reactivities and serum Ig levels in mice which simultaneously carry the XID and CD40 deficiency genes. Int. Immunol. 8:1675.
39. Ridderstad, A., Nossal, G. T. and Tarlinton, D. M. 1996. The xid mutation diminishes memory B cell generation but does not affect somatic hypermutation and selection. J. Immunol. 157:3357.
40. Scher, I., Berning, A. K. and Asofsky, R. 1979. X-linked B lymphocyte defect in CBA/N mice. IV. Cellular and environmental influences on the thymus dependent IgG anti-sheep red blood cell response. J. Immunol. 123:477.
41. Hayakawa, K., Hardy, R. R., Parks, D. R. and Herzenberg, L. A. 1983. The 'Ly-1 B' cell subpopulation in normal immunodefective, and autoimmune mice. J. Exp. Med. 157:202.
42. Stall, A. M. 1988. Ly-1 B cell clones similar to human chronic lymphocytic leukemias routinely develop in older normal mice and young autoimmune (New Zealand Black-related) animals. Proc. Natl Acad. Sci. USA 85:7312.
43. Shlomchik, M. J., Marshak-Rothstein, A., Wolfowicz, C. B., Rothstein, T. L. and Weigert, M. G. 1987. The role of clonal selection and somatic mutation in autoimmunity. Nature 328:895.
44. Schroder, A. E., Greiner, A., Seyfert, C. and Berek, C. 1996. Differentiation of B cells in the nonlymphoid tissue of the synovial membrane of patients with rheumatoid arthritis. Proc. Natl Acad. Sci. USA 93:221.
45. 1 mice during the course of their natural history, after polyclonal stimulation, or following immunization with DNA. J. Clin. Invest. 70:587.
46. LeMaoult, J., Delassus, S., Dyall, R., Nikolic-Zugic, J., Kourilsky, P. and Weksler, M. E. 1997. Clonal expansions of B lymphocytes in old mice. J. Immunol. 159:3866.